RevMedica, Inc.
PrivateLast Round
Grant
Mar 1, 2024
Total Funding Raised
$599,987
Company Overview
RevMedica, Inc. operates in Healthcare & Life Sciences and is based in Middletown, Connecticut. Its latest recorded funding round was a Grant round in March 2024.
RevMedica, Inc. is a medical technology company that develops innovative, semi-reusable surgical stapling systems designed to improve soft tissue management and clinical decision-making.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevMedica, Inc. Comparables
Compare RevMedica, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lexington Medical | 79% | |
| Teleflex Incorporated | 77% | |
| IntoCare Medical Technology | 77% |
For institutional investors. Book with your work email.
RevMedica, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2024 | ||||
| Series A | Jun 14, 2023 | ||||
| Accelerator | Oct 3, 2022 | ||||
| Grant | May 1, 2021 | ||||
| Seed | Dec 31, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RevMedica, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Connecticut Innovations | Seed |
| Telegraph Hill Partners | Series A |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 188% MoM.
- Mar 1, 2024
$294K grant from National Institute of Biomedical Imaging and Bioengineering.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 4, 2026
RevMedica, Inc. appoints Mike Jones as Chief Executive Officer and member of its Board of Directors in Connecticut on Nov 4th '26; he brings more than 30 years of global MedTech leadership experience, most recently as President of Boston Scientific's Endoscopy division.
For institutional investors. Book with your work email.
RevMedica, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RevMedica, Inc.'s valuation, stock price, and market status.
Is RevMedica, Inc. a public or private company?
RevMedica, Inc. is a private company.
What is the current stock price of RevMedica, Inc.?
RevMedica, Inc. is a private company, so its shares have no public market price. Caplight tracks RevMedica, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RevMedica, Inc. worth (valuation)?
Valuation information for RevMedica, Inc. is not publicly available.
Can I buy RevMedica, Inc. stock?
RevMedica, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RevMedica, Inc.'s last funding round?
RevMedica, Inc.'s most recent funding round was Grant on March 1, 2024.
Who are the main investors in RevMedica, Inc.?
Key investors in RevMedica, Inc. include Telegraph Hill Partners.
Will RevMedica, Inc. IPO soon?
No public IPO plans have been announced for RevMedica, Inc..
How can I track RevMedica, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in RevMedica, Inc.'s shares on secondary markets.